XyloCor Therapeutics

King of Prussia, PA · Founded 2013 · Privately Held (backing)

Operator of a bio-pharmaceutical firm intended to develop gene therapy for people with advanced coronary artery disease. XyloCor Therapeutics is based in King of Prussia, PA and was founded in 2013. It was valued at $130 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $122 million across 3 recorded rounds; the latest was a $4 million seed round in Jan 2021.

PMV mark · valuation
$130.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$122.0M
Last round
Seed Round
Jan 2021

Who backs XyloCor Therapeutics?

8 investors
InvestorType
EQT Life SciencesVenture capital
Cornell University—
Fountain Healthcare Partners—
Jeito—
Longwood Fund—
Lumira Ventures—
Sofinnova Investments—
U.S. Department of Health and Human Services—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

XyloCor Therapeutics investors

8 investors are on record for XyloCor Therapeutics, including EQT Life Sciences, Cornell University, Fountain Healthcare Partners and Jeito. The seed round in Jan 2021 drew 5 investors.

Free account
More of XyloCor Therapeutics with a free account
  • ·Watch XyloCor Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like XyloCor Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View